P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuromuscular disorders : NMD 2011-10, Vol.21 (9), p.706-706
Hauptverfasser:	Buyse, G.M, Thijs, D, Goemans, N, van den Hauwe, M, Wei, H, Rummey, C, Meier, T, Mertens, L
Format:	Artikel
Sprache:	eng
Schlagworte:	Neurology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	706
container_issue	9
container_start_page	706
container_title	Neuromuscular disorders : NMD
container_volume	21
creator	Buyse, G.M Thijs, D Goemans, N van den Hauwe, M Wei, H Rummey, C Meier, T Mertens, L
description
doi_str_mv	10.1016/j.nmd.2011.06.973
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_910789707</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S096089661101162X</els_id><sourcerecordid>910789707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1817-fba33592cbef84a5a16e932bc4d1e4fca5ffc79ed33cbec6353b620ac974a7e53</originalsourceid><addsrcrecordid>eNp9kctq3DAUhkVpodO0D9Cddm0WdiXLliwChTBJLxBo6QW6E7J8zGgiSxNJTvBL9SH6ZNUwWXXR1YHD9_9wvoPQa0pqSih_t6_9PNYNobQmvJaCPUEb2gtWNYy3T9GGSE6qXnL-HL1IaU8I7QQXG5S-tnWPv0FaXE54imHGGueHUK2gIw4H8NjpARy2PkO8B59t8DjlZVzxg807bEcYwAcP-O1WZ_D6z-_zAuOrxezAl_W8JLO4UjauKcdw2K0v0bNJuwSvHucZ-vnh-sf2U3Xz5ePn7eVNZWhPRTUNmrFONmaAqW91pykHyZrBtCOFdjK6myYjJIyMFcRw1rGBN0QbKVotoGNn6M2p9xDD3QIpq9kmA85pD2FJSlIieimIKCQ9kSaGlCJM6hDtrOOqKFFHv2qvil919KsIV8VvyVycMlBOuLcQVTIWvIHRRjBZjcH-N_3-n7Rx1luj3S2skPZhib64UVSlRhH1_fi_4_to6aO8-cX-AvfZmuU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>910789707</pqid></control><display><type>article</type><title>P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy</title><source>Elsevier ScienceDirect Journals</source><creator>Buyse, G.M ; Thijs, D ; Goemans, N ; van den Hauwe, M ; Wei, H ; Rummey, C ; Meier, T ; Mertens, L</creator><creatorcontrib>Buyse, G.M ; Thijs, D ; Goemans, N ; van den Hauwe, M ; Wei, H ; Rummey, C ; Meier, T ; Mertens, L</creatorcontrib><identifier>ISSN: 0960-8966</identifier><identifier>EISSN: 1873-2364</identifier><identifier>DOI: 10.1016/j.nmd.2011.06.973</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Neurology</subject><ispartof>Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.706-706</ispartof><rights>2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S096089661101162X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids></links><search><creatorcontrib>Buyse, G.M</creatorcontrib><creatorcontrib>Thijs, D</creatorcontrib><creatorcontrib>Goemans, N</creatorcontrib><creatorcontrib>van den Hauwe, M</creatorcontrib><creatorcontrib>Wei, H</creatorcontrib><creatorcontrib>Rummey, C</creatorcontrib><creatorcontrib>Meier, T</creatorcontrib><creatorcontrib>Mertens, L</creatorcontrib><title>P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy</title><title>Neuromuscular disorders : NMD</title><subject>Neurology</subject><issn>0960-8966</issn><issn>1873-2364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kctq3DAUhkVpodO0D9Cddm0WdiXLliwChTBJLxBo6QW6E7J8zGgiSxNJTvBL9SH6ZNUwWXXR1YHD9_9wvoPQa0pqSih_t6_9PNYNobQmvJaCPUEb2gtWNYy3T9GGSE6qXnL-HL1IaU8I7QQXG5S-tnWPv0FaXE54imHGGueHUK2gIw4H8NjpARy2PkO8B59t8DjlZVzxg807bEcYwAcP-O1WZ_D6z-_zAuOrxezAl_W8JLO4UjauKcdw2K0v0bNJuwSvHucZ-vnh-sf2U3Xz5ePn7eVNZWhPRTUNmrFONmaAqW91pykHyZrBtCOFdjK6myYjJIyMFcRw1rGBN0QbKVotoGNn6M2p9xDD3QIpq9kmA85pD2FJSlIieimIKCQ9kSaGlCJM6hDtrOOqKFFHv2qvil919KsIV8VvyVycMlBOuLcQVTIWvIHRRjBZjcH-N_3-n7Rx1luj3S2skPZhib64UVSlRhH1_fi_4_to6aO8-cX-AvfZmuU</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Buyse, G.M</creator><creator>Thijs, D</creator><creator>Goemans, N</creator><creator>van den Hauwe, M</creator><creator>Wei, H</creator><creator>Rummey, C</creator><creator>Meier, T</creator><creator>Mertens, L</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20111001</creationdate><title>P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy</title><author>Buyse, G.M ; Thijs, D ; Goemans, N ; van den Hauwe, M ; Wei, H ; Rummey, C ; Meier, T ; Mertens, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1817-fba33592cbef84a5a16e932bc4d1e4fca5ffc79ed33cbec6353b620ac974a7e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buyse, G.M</creatorcontrib><creatorcontrib>Thijs, D</creatorcontrib><creatorcontrib>Goemans, N</creatorcontrib><creatorcontrib>van den Hauwe, M</creatorcontrib><creatorcontrib>Wei, H</creatorcontrib><creatorcontrib>Rummey, C</creatorcontrib><creatorcontrib>Meier, T</creatorcontrib><creatorcontrib>Mertens, L</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuromuscular disorders : NMD</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buyse, G.M</au><au>Thijs, D</au><au>Goemans, N</au><au>van den Hauwe, M</au><au>Wei, H</au><au>Rummey, C</au><au>Meier, T</au><au>Mertens, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy</atitle><jtitle>Neuromuscular disorders : NMD</jtitle><date>2011-10-01</date><risdate>2011</risdate><volume>21</volume><issue>9</issue><spage>706</spage><epage>706</epage><pages>706-706</pages><issn>0960-8966</issn><eissn>1873-2364</eissn><pub>Elsevier B.V</pub><doi>10.1016/j.nmd.2011.06.973</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0960-8966
ispartof	Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.706-706
issn	0960-8966 1873-2364
language	eng
recordid	cdi_proquest_miscellaneous_910789707
source	Elsevier ScienceDirect Journals
subjects	Neurology
title	P4.8 Results from a two-year open label intervention study with idebenone (Catena®) in Duchenne muscular dystrophy
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A52%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P4.8%20Results%20from%20a%20two-year%20open%20label%20intervention%20study%20with%20idebenone%20(Catena%C2%AE)%20in%20Duchenne%20muscular%20dystrophy&rft.jtitle=Neuromuscular%20disorders%20:%20NMD&rft.au=Buyse,%20G.M&rft.date=2011-10-01&rft.volume=21&rft.issue=9&rft.spage=706&rft.epage=706&rft.pages=706-706&rft.issn=0960-8966&rft.eissn=1873-2364&rft_id=info:doi/10.1016/j.nmd.2011.06.973&rft_dat=%3Cproquest_cross%3E910789707%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=910789707&rft_id=info:pmid/&rft_els_id=1_s2_0_S096089661101162X&rfr_iscdi=true